Liver transplantation for HBsAg-positive recipients using grafts from HBsAg-positive deceased donors

Youngrok Choi, Jong Young Choi, Nam Joon Yi, Kyoungbun Lee, Shozo Mori, Geun Hong, Hyeyoung Kim, Min Su Park, Tae Yoo, Suk Won Suh, Hae Won Lee, Kwang Woong Lee, Kyung Suk Suh

Research output: Contribution to journalArticlepeer-review

15 Scopus citations

Abstract

This study reports our experience using deceased donor liver grafts from HBsAg-positive donors. We performed eight cases of liver transplantation (LT) using grafts from deceased HBsAg-positive donors between November 2005 and October 2010. The median age of donors was 48 years (range: 26-64). HBV DNA in the serum of donors ranged from 44 to 395 IU/ml, but HBeAg in all donors was negative. Preoperative laboratory and liver biopsy samples revealed the absence of definitive cirrhotic features and hepatitis. All recipients showed HBsAg positive preoperatively except one patient with HBsAg(-) status post previous LT for HBV related liver cirrhosis. The median age was 60 years (range: 46-76) at LT. Post-LT antiviral management consisted of hepatitis B immunoglobulin and antiviral nucleos(t)ide analogues. The median follow-up period was 25.5 months (range: 14-82). Of eight recipients, two recipients experienced serum HBsAg and HBV DNA disappearance postoperatively. Three recipients died of HBV-unrelated causes. The remaining five recipients were stable with normal liver function and no marked pathologic changes on follow-up biopsies. This experience shows that LT using grafts from deceased HBsAg-positive donors is feasible, and may represent a valuable expansion of the pool of organ donors with appropriate antiviral management and monitoring.

Original languageEnglish
Pages (from-to)1173-1183
Number of pages11
JournalTransplant International
Volume26
Issue number12
DOIs
StatePublished - Nov 2013

Keywords

  • HBsAg positive
  • hepatitis B antigen
  • liver transplantation
  • marginal graft

Fingerprint

Dive into the research topics of 'Liver transplantation for HBsAg-positive recipients using grafts from HBsAg-positive deceased donors'. Together they form a unique fingerprint.

Cite this